A strong correlation between expression of Wntless and of human epidermal growth factor receptor 2 in gastric, ovarian, and breast cancers suggests a novel-signalling pathway involving NFκB and STAT3

Jonathan Stewart(GlaxoSmithKline (Netherlands)), Manuel Salto‐Tellez(Queen's University Belfast), Paul B. Mullan(Queen's University Belfast), David Boyle(Queen's University Belfast), David M. Virshup(Duke University), Darragh G. McArt(Queen's University Belfast), Stephen McQuaid(Queen's University Belfast), Jacqueline A. James(Queen's University Belfast), Anne Carson(Queen's University Belfast), Nuala McCabe(Queen's University Belfast), Claire Kidson(Queen's University Belfast), Richard D. Kennedy(Queen's University Belfast), Zhengdeng Lei(National University of Singapore), Glenn McCluggage(Queen's University Belfast), Patrick Tan(Queen's University Belfast), Benedict Yan(National University Hospital)
The Lancet
February 1, 2013
Cited by 1


Related Papers